From the aUniversity of Washington, Seattle, WA
bUniversity of California San Francisco, San Francisco, CA
cInfectious Diseases Research Collaboration, Kampala, Uganda
dKenya Medical Research Institute, Nairobi, Kenya
eUniversity of California Berkeley, Berkeley, CA
fUniversity of Massachusetts Amherst, Amherst, MA.
Submitted January 15, 2020; accepted March 18, 2021
This work was supported by grant numbers U01AI099959, UM1AI068636, and R01AI074345-06A1 from National Institute of Allergy and Infectious Diseases at the National Institutes of Health; by the President’s Emergency Plan for AIDS Relief; and by Gilead Sciences, which provided Truvada.
The authors report no conflicts of interest.
Inquiries regarding data availability should be directed to the SEARCH Scientific Committee at [email protected]. Inquiries about computing code should be addressed to Yiqun Chen at [email protected].
Supplemental digital content is available through direct URL citations in the HTML and PDF versions of this article (www.epidem.com).
Correspondence: Laura B. Balzer, Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, 427 Arnold House, Amherst, MA, 01003. E-mail: [email protected].